Mesa LaboratoriesMLAB +3.92%77 EBITDA Margin % is 10.60% as of Mar. 2026, which is 41% below its 10-year median of 18.06. GuruFocus rates MLAB with a GF Score™ of 77/100 and a GF Value™ of $116.05 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 2,471 Hardware companies, Mesa Laboratories ranks better than 82.27% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Mesa Laboratories's EBITDA for the
three
months ended in Mar. 2026 was $6.8 Mil. Mesa Laboratories's Revenue for the
three
months ended in Mar. 2026 was $63.7 Mil. Therefore, Mesa Laboratories's EBITDA margin for the quarter that ended in Mar. 2026 was 10.60%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Mesa Laboratories EBITDA Margin % Related Terms
Mesa Laboratories EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Mesa Laboratories's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MLAB vs AERG, MVIS, ARBE: EBITDA Margin % Comparison
For the Scientific & Technical Instruments subindustry, Mesa Laboratories's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mesa Laboratories EBITDA Margin % vs Hardware Industry
For the Hardware industry and Technology sector, Mesa Laboratories's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Mesa Laboratories's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mesa Laboratories (MLAB) has a EBITDA Margin % of 10.60% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Mesa Laboratories and its competitors. This is 41% below median its historical median of 18.06. According to the industry distribution chart, Mesa Laboratories ranks #438 out of 2471 companies in the Hardware industry, placing it in the top 17.7%.
Is Mesa Laboratories' EBITDA Margin % too high?
Mesa Laboratories' current EBITDA Margin % of 10.60% is 41% below median its 10-year median of 18.06. The Hardware industry median EBITDA Margin % is 7.00. Mesa Laboratories' value of 10.60% is 51.4% above this industry median. Based on the distribution chart, Mesa Laboratories ranks #438 out of 2471 companies in the Hardware industry, which is in the top quartile — a strong position relative to peers. Overall, Mesa Laboratories has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mesa Laboratories' EBITDA Margin % compare to AERG and MVIS?
According to the Hardware industry distribution chart, Mesa Laboratories ranks #438 out of 2471 companies for EBITDA Margin %. This places Mesa Laboratories in the top 18% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.00. Mesa Laboratories' value of 10.60% is 51.4% above this benchmark. While the company's 10-year median is 18.06 vs. the industry median of 7.00, Mesa Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Hardware company?
The median EBITDA Margin % among Hardware companies is 7.00, based on 2,471 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mesa Laboratories's current EBITDA Margin % of 10.60% is 51.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Mesa Laboratories and its competitors. For the Hardware industry, the median EBITDA Margin % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mesa Laboratories's current EBITDA Margin % is 10.60%, which is 41% below median its own 10-year median of 18.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Mesa Laboratories (MLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is $116.05, compared to a current price of $98.18 — trading 15.4% below its estimated fair value. The current EBITDA Margin % is 10.60%, which is 41% below median its 10-year median of 18.06 and 51.4% above the Hardware industry median of 7.00. Mesa Laboratories' overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Mesa Laboratories (MLAB), the current EBITDA Margin % is 10.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mesa Laboratories (MLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Mesa Laboratories stock appears to be undervalued.
The current stock price of $98.18 is trading 15.4% below its estimated GF Value™ of $116.05.
GuruFocus considers Mesa Laboratories to be Modestly Undervalued.
Key valuation signals for MLAB:
EBITDA Margin %: 10.60% (41% below median its 10-year median of 18.06)
GF Value™: $116.05 vs. price of $98.18 (15.4% below fair value)
Industry Position: 51.4% above the Hardware median (#438 of 2471)
No single metric tells the full story. See the MLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
77GF Score
Get the complete analysis for MLAB
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLAB has been successfully added to your 
